日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study

达雷妥尤单抗四联疗法治疗髓外多发性骨髓瘤患者:来自 II 期前瞻性 EMN19 研究的结果

Beksac, Meral; Fıratlı Tuglular, Tulin; Gay, Francesca; Mina, Roberto; Katodritou, Eirini; Unal, Ali; Cavo, Michele; Ozsan, Guner Hayri; van der Velden, Vincent H J; Beverloo, Berna H; Vermeulen, Michael; van Duin, Mark; Seval, Guldane Cengiz; Sevindik, Omur Gokmen; Merante, Serena; Manousou, Kyriaki; Sonneveld, Peter; Zamagni, Elena; Terpos, Evangelos

Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent

在接受过三类药物治疗的复发/难治性多发性骨髓瘤患者中,Talquetamab 与真实世界医生选择的治疗方案的疗效比较:MonumentTAL-1 与 LocoMMotion/MoMMent 研究的最新分析

Einsele, Hermann; Moreau, Philippe; Bahlis, Nizar; Bhutani, Manisha; Vincent, Laure; Karlin, Lionel; Perrot, Aurore; Goldschmidt, Hartmut; van de Donk, Niels W C J; Ocio, Enrique M; Martínez López, Joaquín; Rodríguez-Otero, Paula; Dytfeld, Dominik; Jakubowiak, Andrzej; Schinke, Carolina; Besemer, Britta; Anguille, Sébastien; Manier, Salomon; Rasche, Leo; Teipel, Raphael; Scheid, Christof; Pawlyn, Charlotte; Cavo, Michele; Diels, Joris; Ghilotti, Francesca; Lau, Bonnie W; Renaud, Thomas; Orel, Oleksiy; Ong, Fenny; Ramos, Diogo F; Ammann, Eric; Parekh, Trilok; Albrecht, Claire; Weisel, Katja; Mateos, María-Victoria

Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies

解决复发/难治性多发性骨髓瘤未满足的需求:意大利德尔菲共识探讨当前挑战和新兴疗法

Cavo, Michele; Bringhen, Sara; Buda, Gabriele; Di Raimondo, Francesco; Musto, Pellegrino; Offidani, Massimo; Petrucci, Maria T; Zamagni, Elena; Zambello, Renato; Berruto, Francesco; Freddi, Rachele; La Malfa, Paola

Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience

下一代流式细胞术和下一代测序技术在多发性骨髓瘤患者可测量残留病灶评估中的应用:一项意大利多中心真实世界协调经验

Oliva, Stefania; Martello, Marina; Saraci, Elona; Armuzzi, Silvia; Solli, Vincenza; Barbato, Simona; Belotti, Angelo; Bolli, Niccolò; Bono, Clara; Buccisano, Francesco; Chiarini, Marco; Irno Consalvo, Maria Antonietta; Cordone, Iole; Drandi, Daniela; Galimberti, Sara; Genuardi, Elisa; Giustini, Viviana; Guerrini, Francesca; Lionetti, Marta; Maheda, Akihiro; Marino, Sara; Masi, Serena; Matera, Antonio; Mengarelli, Andrea; Parrinello, Nunziatina Laura; Roccaro, Aldo Maria; Romano, Alessandra; Rossi, Giovanni; Taurisano, Barbara; Tonini, Alessia; Trimarco, Valentina; Triolo, Anna Maria; Vigliotta, Ilaria; Zambello, Renato; Bruno, Benedetto; Cavo, Michele; Zamagni, Elena; Terragna, Carolina

European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma

欧洲骨髓瘤网络小组关于使用下一代测序对新诊断的多发性骨髓瘤进行预后分层的共识声明

Bolli, Niccolò; D'Agostino, Mattia; Bagratuni, Tina; Boccadoro, Mario; Cavo, Michele; Driessen, Christoph; Einsele, Hermann; Engelhardt, Monika; Gay, Francesca; Gutiérrez, Norma C; Hájek, Roman; Holien, Toril; João, Cristina; Kaiser, Martin; Kortüm, K Martin; Leypoldt, Lisa; Moreau, Philippe; Musto, Pellegrino; Ocio, Enrique M; Raab, Marc S; Rasche, Leo; Schjesvold, Fredrik; Sevcikova, Tereza; Terpos, Evangelos; Touzeau, Cyrille; Van de Donk, Niels W C J; van Duin, Mark; Weisel, Katja; Zamagni, Elena; Cupedo, Tom; Sonneveld, Pieter; Terragna, Carolina

Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform

基于机器学习的多发性骨髓瘤风险分层策略:来自 EMN-HARMONY 联盟平台的启示

Mosquera Orgueira, Adrian; Gonzalez Perez, Marta Sonia; D'Agostino, Mattia; Cairns, David A; Larocca, Alessandra; Palacios, Juan José Lahuerta; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Pérez Míguez, Carlos; Rojas Martínez, Javier Alberto; Mai, Elias K; Crucitti, Davide; Salwender, Hans; Dall'Olio, Daniele; Castellani, Gastone; Piñeiro Fiel, Manuel; Bringhen, Sara; Zweegman, Sonja; Cavo, Michele; Iqbal, Sofía; Hernandez Rivas, Jesus Maria; Bruno, Benedetto; Cook, Gordon; Kaiser, Martin F; Goldschmidt, Hartmut; Van De Donk, Niels W C J; Jackson, Graham; San-Miguel, Jesús F; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter

Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma

独特的分子检测(UMA):一种用于高效、全面地进行多发性骨髓瘤基因组分析和风险分层的下一代测序靶向检测平台。

Poletti, Andrea; Taurisano, Barbara; Mazzocchetti, Gaia; Lionetti, Marta; Martello, Marina; Vuong, Viola Meixian; Solli, Vincenza; Marzocchi, Giulia; Maeda, Akihiro; Vigliotta, Ilaria; Borsi, Enrica; Armuzzi, Silvia; Pistis, Ignazia; Marella, Alessio; Fabris, Sonia; Tacchetti, Paola; Mancuso, Katia; Rizzello, Ilaria; Pantani, Lucia; Testoni, Nicoletta; Cavo, Michele; Zamagni, Elena; Bolli, Niccolò; Terragna, Carolina

Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial

伊沙妥昔单抗联合硼替佐米、来那度胺和地塞米松治疗不适合移植的新诊断多发性骨髓瘤患者:IMROZ试验的虚弱亚组分析

Manier, Salomon; Dimopoulos, Meletios-Athanasios; Leleu, Xavier P; Moreau, Philippe; Cavo, Michele; Goldschmidt, Hartmut; Orlowski, Robert Z; Tron, Muriel; Tekle, Christina; Brégeault, Marie-France; Shafer, Andrea T; Beksac, Meral; Facon, Thierry

Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States

Belantamab mafodotin 单药治疗复发或难治性多发性骨髓瘤:一项美国真实世界观察性研究

Hultcrantz, Malin; Kleinman, David; Vij, Ravi; Escalante, Fernando; Delforge, Michel; Kotowsky, Nirali; Bitetti, Jacopo; Boytsov, Natalie; Camadoo-O'Byrne, Leena; Happ, Lindsey Powers; Germain, Guillaume; Urosevic, Ana; Mahendran, Malena; Duh, Mei Sheng; Laliberte, Francois; Cavo, Michele; Lee, Hans C

Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials

在 DREAMM-7 和 DREAMM-8 试验中调整 belantamab mafodotin 的剂量以平衡疗效和耐受性

Mateos, María-Victoria; Trudel, Suzanne; Quach, Hang; Robak, Paweł; Beksac, Meral; Pour, Ludek; Hus, Marek; Kim, Kihyun; Zherebtsova, Vera; Delimpasi, Sosana; Jelínek, Tomas; Ward, Christopher; Ho, P Joy; Vorobyev, Vladimir; Pitombeira de Lacerda, Marcelo; Aparecida-Martinez, Gracia; Spicka, Ivan; Radocha, Jakub; Cavo, Michele; Cerchione, Claudio; Fu, Chengcheng; Suzuki, Kazuhito; Rogers, Rachel; Phillips-Jones, Amy; Wang, Zhaohui; Baig, Hena; Wilkes, Jodie; Zhou, Xiaoou L; Lewis, Eric; Eccersley, Lydia; Sule, Neal; Paka, Prani; Opalinska, Joanna B; Mukhopadhyay, Pralay; Hungria, Vania; Dimopoulos, Meletios Athanasios